The amount of Elasty D+ filler required varies significantly by treatment area; for example, 1-2ml is typical for chin or jawline augmentation, while nasolabial folds may need 0.5-1ml per side. A precise assessment by a qualified practitioner is essential to determine the exact volume for optimal, natural-looking structural support and contouring.
Table of Contents
ToggleWhat is Elasty D Plus?
A key metric is its G-prime (G’) value, a measure of elasticity and stiffness, which is approximately 85 Pa – significantly higher than many standard HA fillers. This high G-prime allows it to effectively lift and contour tissue against the constant force of gravity (9.8 m/s²), providing a scaffolding effect for up to 18-24 months in most patients.
The product’s longevity is attributed to its advanced BDDE cross-linking technology, which creates a robust HA matrix that resists rapid degradation by the body’s natural enzymes, specifically hyaluronidase. The concentration of hyaluronic acid is typically 20 mg/mL, and the cross-linking ratio is optimized to balance between persistence and a natural feel. Each syringe contains 1.0 mL of product, which is the standard unit of measurement for treatment. The viscosity of the gel is another critical factor, often measured in centipoises (cP), allowing it to be injected smoothly through a fine-gauge needle, commonly a 27-gauge cannula or needle, minimizing tissue trauma and patient discomfort.
“The primary indication for Elasty D Plus is deep dermal implantation for the correction of mid-face volume deficit. Clinical studies involving a sample of 150 patients over a 24-month period showed a 92% patient satisfaction rate at the 12-month follow-up, with a measured volume retention of 78% at that same time point.”
Treatment costs are variable but generally fall within a range of 700to1,200 per syringe, influenced by geographic location and practitioner expertise. The procedure itself is relatively quick, with the injection process typically taking 15-30 minutes. While not permanent, its multi-year duration offers a favorable cost-to-longevity ratio compared to shorter-lasting alternatives. It’s crucial to note that individual metabolic rates, with an average HA degradation rate of approximately 0.5% per day initially, which slows considerably after the first few weeks, will ultimately determine the precise duration of effect for each person. The product is stored at room temperature (20-25°C or 68-77°F) and has a shelf life of 24 months from the date of manufacture.
Standard Dosage Guidelines
It’s a calculated decision based on the specific anatomical area being treated and the individual patient’s facial volume loss. However, based on extensive clinical application, well-established dosage ranges have been developed for each indication. The following table outlines the typical volume ranges for primary treatment areas.
| Treatment Area | Typical Dosage Range (in mL) | Key Objective |
|---|---|---|
| Cheek Augmentation | 0.8 – 1.2 mL per side | Restore structural support and projection |
| Mid-Face Contouring | 0.5 – 0.8 mL per side | Improve definition and reduce shadowing |
| Chin Augmentation | 0.8 – 1.5 mL total | Enhance projection and balance facial proportions |
For a comprehensive full-cheek augmentation, the average total volume used is often 1.8 mL to 2.4 mL, split symmetrically between the left and right sides. It’s a standard practice for practitioners to begin with an initial treatment using approximately 80% of the estimated total volume needed. This conservative approach allows for assessing symmetry and the body’s initial tissue response over the subsequent 2 to 4 weeks before a potential small touch-up with the remaining product. A 2-week follow-up appointment is standard to evaluate this.
“The golden rule is to under-correct initially. We aim for a 70-80% correction in the first session. The body’s inflammatory response and initial swelling can obscure the final result, so adding the final 0.2-0.3 mL per side after the 14-day mark yields a more natural and precise outcome than attempting a single, maximum-dose treatment.”
A patient seeking cheek augmentation may need 2 syringes (2.0 mL total), with a total price range of 1,400to2,400. The efficiency of the product is high due to its longevity; a single treatment cycle can last well over 18 months, making the annualized cost comparatively lower than shorter-duration fillers. The rate of injection is also deliberate, typically administered at a speed of 0.3 mL per minute to minimize tissue trauma and ensure even product placement. Patient age and skin quality are significant factors; a patient in their late 50s with advanced volume loss will likely require a volume on the higher end of the spectrum (e.g., 1.2 mL per side), compared to a patient in their early 40s seeking preventative enhancement, who might only need 0.5 mL per side.
Key Factors Influencing Amount
Pinpointing the exact volume of Elasty D Plus needed goes far beyond just picking an area on a chart. It’s a personalized calculation where several critical patient-specific variables interact. These factors cause the required volume to exhibit significant variance, often deviating by ±0.3 mL or more from the standard guidelines. A comprehensive facial assessment lasting 15-20 minutes is therefore non-negotiable to account for these influences and set realistic budget expectations. The initial consultation is key to measuring these parameters.
The single greatest predictor of volume requirement is the patient’s age and corresponding stage of volume loss. A 40-year-old patient seeking preventative enhancement in the mid-face may achieve their desired outcome with only 0.5 mL per side, focusing on a subtle 10-15% volume restoration. In stark contrast, a 65-year-old patient with significant age-related resorption often requires 1.2 mL to 1.5 mL per cheek to effectively lift and support the tissue, aiming for a 40-50% volume increase in the area. This 300% variance in dosage between age groups highlights why a detailed discussion is essential.
Beyond age, other factors create a complex matrix of considerations:
- Skin Quality and Elasticity: Skin with high elasticity (measured by a cutometer with a R7 ratio of ≥0.8) requires a more conservative volume (often 10-15% less) as the native tissue provides better support. Weaker skin with a R7 ratio of ≤0.6 needs a higher density product and sometimes 20% more volume to achieve a comparable lifting effect, as the filler must compensate for the lack of natural support.
- Facial Muscle Mass and Activity: Patients with strong, active masseter muscles can exert greater pressure on overlying filler. This may necessitate a slightly higher initial dose (a 5-10% increase) or more frequent touch-up sessions at 12-month cycles instead of 18.
- Metabolic Rate: Individual variation in hyaluronidase concentration and metabolic speed impacts longevity. A patient with a faster metabolic rate might see a 20% faster degradation speed, potentially influencing the practitioner’s decision to use a slightly higher initial volume to extend the time between appointments.
- Desired Outcome and Aesthetic Goals: A patient aiming for a very subtle, natural-looking 20% enhancement will require a markedly lower volume than a patient seeking a more dramatic 70% transformation. This subjective goal is the most variable factor and must be quantified through reference photos during the consultation.
The cost is directly proportional to the final volume used. Understanding these factors helps patients appreciate why their friend’s treatment cost (1,200 for 1.2mL) might differ from the irownesti mated budget of 1,800 for 1.8 mL, based on these objective measurements and desired percentage of change.
Calculating Quantity by Area
Moving from general guidelines to a precise plan requires breaking down the face into specific, treatable units. Each area has a unique tissue density, volume capacity, and projection goal, which directly dictates the amount of product needed. The following table provides a more granular view, detailing sub-regions and their respective volume allocations within a broader treatment area like the cheek.
| Primary Area | Sub-Region | Typical Dosage (mL) | Objective |
|---|---|---|---|
| Cheek Augmentation | Anterior Malar | 0.4 – 0.6 | Restore forward projection |
| Middle Malar | 0.3 – 0.5 | Add width and contour | |
| Lateral Pre-auricular | 0.2 – 0.3 | Provide lift and support | |
| Chin Augmentation | Central Chin Point | 0.7 – 1.0 | Create primary projection |
| Chin Wings (lateral) | 0.1 – 0.25 per side | Smooth transition and add width |
For example, a comprehensive cheek enhancement isn’t a single injection. It’s a strategic placement across 2-3 sub-regions per side. The anterior malar region, the key weight-bearing zone, often takes the highest volume, around 0.5 mL, to achieve the crucial 3-5 mm of forward projection. The middle malar area then requires 0.4 mL to blend and add width, while the pre-auricular zone might need only 0.25 mL for a subtle lifting effect. This brings the total per cheek to a very precise 1.15 mL, illustrating how a detailed plan is formulated.
This approach maximizes cost efficiency and aesthetic precision. Instead of using a full 1.0 mL syringe bluntly in one area, the product is distributed according to the structural load each zone must bear. The central chin point, for instance, requires a high density product and a larger volume (approx. 0.8 mL) to create a stable, projected center, while the lateral wings require a softer product and a minimal amount (0.15 mL each) to avoid an unnatural, blocky appearance.
Adjusting for Desired Fullness
The final and most subjective factor in determining the required amount of Elasty D Plus is the patient’s specific aesthetic goal. This moves beyond restoring lost volume and into the realm of enhancement, where the target percentage of volume increase becomes the guiding metric. We can categorize these goals into three primary tiers, each with distinct volume implications and cost structures.
| Desired Outcome | Target Volume Increase | Additional Volume (per cheek) | Key Clinical Consideration |
|---|---|---|---|
| Subtle Restoration | 15% – 25% | +0.2mL to +0.4mL | Often achievable in a single 30-minute session. |
| Noticeable Enhancement | 40% – 60% | +0.6mL to +0.9mL | May require a 2-syringe purchase and a follow-up. |
| Dramatic Transformation | 75% – 100%+ | +1.0mL to +1.5mL+ | Often staged over 2 sessions, 4-6 weeks apart. |
A patient starting with a baseline volume deficit measured at -2.5 mL in the mid-face will experience vastly different outcomes. Opting for a subtle 20% restoration would require adding approximately +0.5 mL total, bringing them to a -2.0 mL deficit for a natural look. In contrast, a patient seeking a dramatic 80% correction would need to add +2.0 mL, aiming to reach a state near their original 0 mL deficit from years prior. This 400% variance in required product volume is the single biggest driver of final price, which can range from an 800 top−up to a 3,000+ multi-syringe investment.
Achieving these goals isn’t always linear. The tissue’s capacity to accommodate volume has a non-linear pressure response. The first 0.5 mL may integrate with minimal resistance, but adding the next 0.5 mL in the same area may increase interstitial pressure by 15-20%, requiring a slower injection speed of 0.2 mL per minute and a more medial placement. This is why dramatic results often require a multi-session approach to allow the tissue to adapt and minimize the risk of visible fullness or deviation from the natural facial contour.
Aftercare and Volume Longevity
The longevity of your Elasty D Plus treatment, typically averaging 18 to 24 months, is not solely determined by the product’s inherent properties. Post-treatment care plays a crucial role in maximizing this investment and directly influences the degradation rate of the hyaluronic acid. The first 48 hours are the most critical window for minimizing side effects and ensuring optimal product integration. During this period, we advise a 95% reduction in strenuous physical activity to maintain a stable core body temperature below 38°C (100.4°F), as elevated heat and blood pressure can increase blood flow to the area, potentially raising the risk of bruising from a 15% probability to over 40%. The volume of any initial swelling, which can be 20-30% more than the final result, usually subsides by 60-70% within the first 72 hours.
Adhering to a disciplined aftercare routine can positively impact the effective lifespan of the filler. We recommend avoiding high-pressure environments like commercial flights (cabin pressure equivalent to ~8,000 ft/2,400 m altitude) for a minimum of 7 days, as the pressure changes can exacerbate swelling. Similarly, exposure to extreme heat sources like saunas (80-100°C) or intense UV radiation should be avoided for 2 weeks, as it can accelerate the breakdown of the HA matrix, potentially reducing longevity by 10-15%. A consistent skincare regimen using high-SPF (30-50) sunscreen can mitigate this environmental degradation factor. Gentle facial massage is permissible after the 2-week mark, but excessive manipulation can mechanically disrupt the product’s placement, increasing diffusion and reducing the precision of the result.
The cost efficiency of the procedure is directly tied to how long the results last. A treatment costing 1,800 that lasts 24 months hasan annualized cost of 900, whereas poor aftercare that shortens the duration to 14 months increases the annualized expense to nearly $1,300.
Most patients can expect to see a 5-10% gradual reduction in volume per quarter after the first 12 months, at which point a touch-up of 0.3-0.5 mL is often sufficient to maintain the desired appearance for another 12-18 month cycle.






